Clinical trial
Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic…
NCT00003700 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003700 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia |
| Official title | Phase II Study in Adults With Untreated Acute Lymphoblastic Leukemia Testing Increased Doses of Daunorubicin During Induction, and Cytarabine During Consolidation, Followed by High-Dose Methotrexate and Intrathecal Methotrexate in Place of Cranial Irradiation |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | G-CSF, asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, prednisone, vincristine sulfate and 1 more |
| Enrollment | 163 |
| Start date | Jan 1, 1999 |
| Primary completion | Feb 1, 2004 |
| Completion | Jan 1, 2010 |
| First posted | May 20, 2004 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: